Correlation Between Vitamin D and Symptoms Severity of Autonomic Nervous Mediated Syncope Child and it 's RAAS

Kongyujie

Status and phase

Unknown

Early Phase 1

Conditions

Vitamin D

Treatments

Device: Full automatic chemiluminescence measuring instrument

Drug: Vitamin D

Study type

Interventional

Funder types

Other

Identifiers

NCT04844957

2021A-057

Details and patient eligibility

About

children ; autonomic nervous mediated syncope； vitamin D ; symptom score ; renin-angiotensin-aldosterone-system

Full description

children with autonomic nervous mediated syncope have seriously affects children's physical and mental health and quality of life, and the incidence rate is also increasing year by year. But the current treatment measures are not ideal, Therefore, we need to look for new biological indicators, according to different biological indicators to develop different treatment options, so as to improve the current situation of poor treatment of children with NMS

Enrollment

100 estimated patients

Sex

All

Ages

5 to 14 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Children diagnosed with OI;
Compliance with the diagnostic guidelines for Syncope in children (2016 edition) and 2018 syncope in children and adolescents in the cardiovascular group of the Society of Pediatrics, Chinese Medical Association The diagnostic criteria of Oi in the Diagnostic and therapeutic guidelines.

Exclusion criteria

Taken 3 months prior to admission Vitamin D or hormone drugs;
Heart, brain, nerves, metabolism, blood and other apparatus Syncope or aura of syncope caused by a qualitative disease;